These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1776 related articles for article (PubMed ID: 26195256)

  • 21. Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain.
    Duarte AC; Hrynchak MV; Gonçalves I; Quintela T; Santos CR
    J Neuroendocrinol; 2016 Nov; 28(11):. PubMed ID: 27632792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy for Alzheimer's disease.
    Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
    Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mathematical model demonstrating the role of interstitial fluid flow on the clearance and accumulation of amyloid β in the brain.
    Chen CY; Tseng YH; Ward JP
    Math Biosci; 2019 Nov; 317():108258. PubMed ID: 31562868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clearance of beta-amyloid in the brain.
    Ueno M; Chiba Y; Matsumoto K; Nakagawa T; Miyanaka H
    Curr Med Chem; 2014; 21(35):4085-90. PubMed ID: 25312211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advancements in Strategies for Abnormal Protein Clearance in Alzheimer's Disease.
    Gong B; Ji W; Chen X; Li P; Cheng W; Zhao Y; He B; Zhuang J; Gao J; Yin Y
    Mini Rev Med Chem; 2022; 22(17):2260-2270. PubMed ID: 35156576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipopolysaccharide impairs amyloid β efflux from brain: altered vascular sequestration, cerebrospinal fluid reabsorption, peripheral clearance and transporter function at the blood-brain barrier.
    Erickson MA; Hartvigson PE; Morofuji Y; Owen JB; Butterfield DA; Banks WA
    J Neuroinflammation; 2012 Jun; 9():150. PubMed ID: 22747709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models.
    Arbel-Ornath M; Hudry E; Eikermann-Haerter K; Hou S; Gregory JL; Zhao L; Betensky RA; Frosch MP; Greenberg SM; Bacskai BJ
    Acta Neuropathol; 2013 Sep; 126(3):353-64. PubMed ID: 23818064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease.
    Watanabe K; Uemura K; Asada M; Maesako M; Akiyama H; Shimohama S; Takahashi R; Kinoshita A
    Mol Brain; 2015 Dec; 8(1):82. PubMed ID: 26637371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
    Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
    Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.
    Cirrito JR; Deane R; Fagan AM; Spinner ML; Parsadanian M; Finn MB; Jiang H; Prior JL; Sagare A; Bales KR; Paul SM; Zlokovic BV; Piwnica-Worms D; Holtzman DM
    J Clin Invest; 2005 Nov; 115(11):3285-90. PubMed ID: 16239972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Glymphatic-Lymphatic Continuum: Opportunities for Osteopathic Manipulative Medicine.
    Hitscherich K; Smith K; Cuoco JA; Ruvolo KE; Mancini JD; Leheste JR; Torres G
    J Am Osteopath Assoc; 2016 Mar; 116(3):170-7. PubMed ID: 26927910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ApoE: the link between Alzheimer's-related glucose hypometabolism and Aβ deposition?
    Patil SP; Ballard R; Sanchez S; Osborn J; Santangelo D
    Med Hypotheses; 2012 Apr; 78(4):494-6. PubMed ID: 22285195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mirror Image of the Amyloid-β Species in Cerebrospinal Fluid and Cerebral Amyloid in Alzheimer's Disease.
    Catania M; Di Fede G; Tonoli E; Benussi L; Pasquali C; Giaccone G; Maderna E; Ghidoni R; Tagliavini F
    J Alzheimers Dis; 2015; 47(4):877-81. PubMed ID: 26401767
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease.
    Golde TE; Dickson D; Hutton M
    Curr Alzheimer Res; 2006 Dec; 3(5):421-30. PubMed ID: 17168641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
    Shackleton B; Crawford F; Bachmeier C
    Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.
    Banks WA; Kumar VB; Farr SA; Nakaoke R; Robinson SM; Morley JE
    J Alzheimers Dis; 2011; 23(4):599-605. PubMed ID: 21098986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 89.